e-learning
resources
Vienna 2012
Sunday, 02.09.2012
New aspects of lung cancer biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
G. Galffy, D. Bartusek, A. Cseh, V. Papp, E. Zelenak, Z. Sutto, B. Vasarhelyi, G. Losonczy (Budapest, Hungary)
Source:
Annual Congress 2012 - New aspects of lung cancer biology
Session:
New aspects of lung cancer biology
Session type:
Thematic Poster Session
Number:
1218
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Galffy, D. Bartusek, A. Cseh, V. Papp, E. Zelenak, Z. Sutto, B. Vasarhelyi, G. Losonczy (Budapest, Hungary). Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 1218
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Source: Eur Respir J 2001; 17: 946-953
Year: 2001
T regulatory cells in exacerbation control of chronic obstructive pulmonary disease of mild and moderate stage
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Accumulation of dendritic cells in small airways of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007
Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
Phenotypically aberrant and clonal T cell in the lung of patients with refractory coeliac disease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Decreased small airway and alveolar mature dendritic cells in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Evaluation of dendritic cell population in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept